FDA Supplement Guidance Likely To Remain Onerous, Attys Say

Law360, New York (June 21, 2012, 9:40 PM EDT) -- The U.S. Food and Drug Administration's decision to revise draft guidance that would increase the burden on dietary supplement makers to prove a product's safety may seem like a win for the industry, but the agency likely won't drop many of the elements that companies describe as the most burdensome, attorneys say.

The FDA alerted supplement trade organizations on Tuesday that it planned on issuing a revised draft guidance for new dietary ingredients, following a meeting between agency leaders and Sens. Tom Harkin, D-Iowa, and Orrin...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.